You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EUGOGO

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Eye Disease Trial in Shanghai (IBI311, )

Recruiting
  • Thyroid Eye Disease
  • IBI311
  • placebo
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital, Shanghai JiaoTong University S
Mar 20, 2023

Thyroid Eye Disease, Graves Orbitopathy Trial in Germany (Secukinumab, Placebo)

Recruiting
  • Thyroid Eye Disease
  • Graves Orbitopathy
  • Essen, Germany
  • +6 more
Jul 14, 2022

Graves' Disease Trial (Mycophenolate Mofetil, Oral, 250 Mg, methimazole, oral, 10mg)

Not yet recruiting
  • Graves' Disease
  • Mycophenolate Mofetil, Oral, 250 Mg
  • methimazole, oral, 10mg
  • (no location specified)
Sep 28, 2023

Graves' Orbitopathy Trial in Pisa (Atorvastatin 20mg, Placebo)

Not yet recruiting
  • Graves' Orbitopathy
  • Atorvastatin 20mg
  • Placebo
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
Sep 8, 2021

Hyperthyroidism/Thyrotoxicosis Trial in Cheras (radioactive iodine)

Completed
  • Hyperthyroidism/Thyrotoxicosis
  • radioactive iodine
  • Cheras, Kuala Lumpur, Malaysia
    Hospital Canselor Tuanku Muhriz
Aug 20, 2022

Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)

Recruiting
  • Graves Ophthalmopathy
  • Tocilizumab 20 Mg/mL Intravenous Solution
  • MethylPREDNISolone Injectable Solution
  • Milano, MI, Italy
  • +3 more
Aug 3, 2022

Thyroid Associated Ophthalmopathy, Hypercholesterolemia Trial in Pisa (Atorvastatin, Methylprednisolone)

Completed
  • Thyroid Associated Ophthalmopathy
  • Hypercholesterolemia
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology I and II
Aug 12, 2021

Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)

Recruiting
  • Graves Ophthalmopathy
  • +8 more
  • Doxycycline hyclate
  • Placebo
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Nov 16, 2021

Thyroid Eye Disease Trial (peri-levator betamethasone injection, peri-levator triamcinolone injection, peri-levator and

Not yet recruiting
  • Thyroid Eye Disease
  • peri-levator betamethasone injection
  • +3 more
  • (no location specified)
Jul 15, 2021

Ophthalmopathy, Thyroid-Associated Trial in Gothenburg, Mölndal, Stockholm (Rituximab, Iv Methylprednisolone, peroral

Active, not recruiting
  • Ophthalmopathy, Thyroid-Associated
  • Gothenburg, Sweden
  • +4 more
Sep 17, 2021

Graves Disease Trial in Hong Kong (Echopulse)

Completed
  • Graves Disease
  • Echopulse
  • Hong Kong, Hong Kong
    Queen Mary Hospital
May 17, 2022

Thyroid Eye Disease Trial in Germany, Italy, United States (Teprotumumab)

Completed
Has Results
  • Thyroid Eye Disease
  • Teprotumumab
  • Beverly Hills, California
  • +12 more
Dec 9, 2021

Heart Rhythm After Intravenous Methylprednisolone Administration

Completed
  • Graves Disease
  • +5 more
  • Intravenous Methylprednisolone
  • (no location specified)
May 13, 2020

Thyroid Eye Disease Trial in Tehran (drug, dietary supplement, other)

Withdrawn
  • Thyroid Eye Disease
  • Tehran, Iran, Islamic Republic of
    Rassoul Akram Hospital
Dec 18, 2021

Graves Ophthalmopathy Trial in Newcastle upon Tyne (Otelixizumab - low dose, Otelixizumab - medium low dose, Otelixizumab -

Terminated
Has Results
  • Graves Ophthalmopathy
  • Otelixizumab - low dose
  • +5 more
  • Newcastle upon Tyne, United Kingdom
    GSK Investigational Site
Oct 8, 2020

Thyroid Associated Ophthalmopathy Trial (Orbital radiotherapy, Methylprednisolone)

Not yet recruiting
  • Thyroid Associated Ophthalmopathy
  • (no location specified)
Mar 24, 2020

B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease

Terminated
  • Thyroid Eye Disease
    • Pittsburgh, Pennsylvania
      University of Pittsburgh
    Nov 14, 2019

    Graves Disease, Graves Ophthalmopathy, Liver Diseases Trial (every week IVMP therapy, very high doses IVMP therapy)

    Completed
    • Graves Disease
    • +13 more
    • every week IVMP therapy
    • very high doses IVMP therapy
    • (no location specified)
    Sep 11, 2018

    Thyroid-Associated Ophthalmopathy Trial in Dalian (Methylprednisolone, 99Tc-MDP(99Technetium-Methylenediphosphonate Injection))

    Completed
    • Thyroid-Associated Ophthalmopathy
    • Dalian, Liaoning, China
      Affiliated Zhongshan Hospital of Dalian University
    May 13, 2019

    Blood Pressure

    Completed
    • Graves Disease
    • +4 more
    • (no location specified)
    Jul 17, 2018

    Coagulation After Intravenous Methylprednisolone Administration

    Completed
    • Graves' Disease
    • +3 more
    • (no location specified)
    May 12, 2018

    Thyroid Associated Ophthalmopathies, Thyroid-Associated Ophthalmopathy Trial in Worldwide (teprotumumab, normal saline)

    Completed
    Has Results
    • Thyroid Associated Ophthalmopathies
    • Thyroid-Associated Ophthalmopathy
    • Los Angeles, California
    • +14 more
    Mar 27, 2018

    Graves Ophthalmopathy Trial (Azithromycin)

    Withdrawn
    • Graves Ophthalmopathy
    • (no location specified)
    Apr 25, 2017

    Thyroid Associated Ophthalmopathies, Graves´ Ophthalmopathy, Thyroid Eye Disease Trial in Spain (Tocilizumab (RoActemra®),

    Completed
    • Thyroid Associated Ophthalmopathies
    • +2 more
    • Tocilizumab (RoActemra®)
    • Sterile 0.9% Sodium Chloride
    • Santiago de Compostela, A Coruña, Spain
    • +8 more
    Jan 19, 2016

    Graves' Disease Trial in Milan (LAB4)

    Unknown status
    • Graves' Disease
    • LAB4
    • Milan, Italy
      Fondazione Ca' Granda Ospedale Maggiore Policlinico
    Feb 26, 2015